Q3 2025 Earnings Call Transcript October 30, 2025 DexCom, Inc. beats earnings expectations. Reported EPS is $0.61, ...

Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

Get key insights from DexCom’s Q3 2025 earnings: robust revenue growth, new product launches, updated guidance, and future opportunities.

However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...

After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...

Continuous glucose monitors — the tiny sensors once reserved for people with diabetes — are now appearing on the arms of ...

The waiting room hums with quiet rituals: a cough behind a magazine, the clack of a walking stick, the kettle in the corner ...

DexCom, Inc. DXCM is scheduled to report third-quarter 2025 resultson Oct. 30, after the closing bell. In the last reported ...

The AI health companion unifies data from wearables and habits across sleep, fitness, and nutrition into personalized ...

OpenAI’s deepfake video application, Sora 2, has put a halt to the use of Martin Luther King Jr.‘s likeness. This move comes in the wake of criticism from Bernice A. King, King’s daughter, who voiced ...